National Pharmacy Association (NPA) - News updates

Certain pages on this news feed are only available to NPA members and hence requires members to log-in accordingly


NPA Board member election for Area 12

An election is set to take place for a new NPA board member in Area 12 which covers the West Midlands.   The nomination packs should have already reached members and the deadline for return of completed nomination forms is noon on Monday 10th February.   The NPA Board sets the policy, strategic direction and objectives for the Association.  Board members are expected to contribute actively to debate and deliver fresh thinking throughout the period of their service.   In addition to NPA Board meetings, Board members also participate in Standing Committees and/or Working Groups of the Board.  The main objective is to ensure that the NPA is advancing the interests of independent community pharmacy owners, to the benefit ultimately of patients and communities.   NPA Election timetable:   Nominations stage Dispatch of nomination packs by post to qualifying members – 13th January Nominations will close – Noon 10th   Election stage Despatch of election papers to qualifying members – 24th February Last date for receipt of voting papers –  Noon 20th March Declaration of results – 24th March Check on www.npa.co.uk/election for updates.…

England: 2 weeks to go until the PQS review period begins – are you ready?

Dear Superintendent, Welcome to the first update of 2020 from the NPA. We wish you a happy and healthy year ahead. Topics covered in this update: Pharmacy Quality Scheme (PQS) Healthy Living Pharmacy (HLP) Community Pharmacist Consultation Service (CPCS) 1.Pharmacy Quality Scheme (PQS) The Pharmacy Quality Scheme (PQS) has been underway since 1 October 2019, and the review period is fast approaching. In this update, we have focussed on providing you with information to conduct a quick check of the key actions that you should have taken already, and some steps that you still have time to complete, to put you in a good position to make your declarations to claim PQS payments in February 2020. Key points to note regarding the PQS Where your pharmacy offers the NHS community pharmacy flu vaccination Advanced Service and/or you have claimed an Aspiration payment, you must have completed registration on the Manage Your Service (MYS) application. MYS is the only platform for making declarations and claiming payments for the PQS and the flu vaccination Advanced Service. (Please note the Snap Survey is not being used.) If you wish to claim PQS payments, then you must make the PQS declarations on the NHS Business services Authority’s (NHSBSA’s) MYS portal, within the review period, that your pharmacy has met the relevant quality criteria.…

Community Pharmacy Patient Safety Group – Our 2020 priorities

The Community Pharmacy Patient Safety Group (CPPSG) is now entering the fifth year of its collaborative approach to sharing and learning patient safety culture and practice and has set out core priority areas to work on in 2020. The CPPSG is made up of 19 like-minded people Medication Safety officers (MSOs) with a passion for patient safety. We seek to collaborate and find practical solutions to safety challenges, raise awareness of the importance of reporting, learning and sharing, champion the development of a safety culture and create consistency across community pharmacy. The NPA holds the role of MSO for all independent community pharmacies in England with fewer than 50 branches. The priorities for 2020 include: Supporting the profession to embed patient safety principles at every level Proactively monitor and investigate the safety implications of professional practice Influence national level mechanisms to improve patient safety Share patient safety messages widely For further information on this or any other query, please contact the NPA Pharmacy Services team on 01727 891 800 or email pharmacyservices@npa.co.uk. Produced by the NPA Pharmacy Services team January 2020.…

The National Pharmacy Association’s board and committees convened on 13-14 January in Belfast

Latest updated NPA malaria prophylaxis information leaflet – available now

An updated version of the “NPA Malaria prophylaxis information” leaflet, which expires 30 June 2020, has been produced by the NPA Pharmacy Services team. The leaflet is available to download from the “Travel health” section of the NPA website; this can then be printed off if access to a hard copy is required. NPA members will not receive a hard copy of the updated leaflet because of the NPA’s continuing move towards making all documents available as electronic downloads, in-line with our environmental policy. There have been no major changes made to the malaria prophylaxis recommendations; however, to aid clarification, minor changes to wording used for chemoprophylaxis recommendations for some countries have been made and some general information has been added/amended . These changes include: Algeria There is no risk of malaria in all areas of Algeria Pregnancy – supplementation with 5mg of folic acid is recommended for the length of time that proguanil is taken during all trimesters of pregnancy South Africa The word “only” has been added after “between September and May” to emphasise that the malaria chemoprophylaxis requirements that apply to the low altitude areas of Limpopo and Mpumalanga (bordering Mozambique and Zimbabwe), including Kruger National Park, are seasonal Swaziland – name change to Eswatini Swaziland has undergone a name change and is now officially known as “Eswatini”; this country has therefore been moved to the relevant alphabetical section of the chemoprophylaxis table For country-/area-specific advice on malaria chemoprophylaxis, NPA members can contact the Pharmacy Services team or use the latest version of the NPA Malaria prophylaxis information leaflet.…

NPA members first to hear from Northern Ireland’s new Chief Pharmaceutical Officer

Class 4 drug alert – Caution in Use – Zapain tablets 30mg/500mg (codeine phosphate /paracetamol)

Ref: EL (20)A/01 14 January 2020 Zapain tablets 30mg/500mg (Codeine Phosphate/Paracetamol) (Manufactured by Advanz Pharma) PL 12762/0034 A Class 4 medicines defect information alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for specific batches of Zapain tablets 30mg/500mg (codeine phosphate/paracetamol). Advanz Pharma has informed the MHRA of a discrepancy on the packaging of affected batches containing tablets that have been incorrectly labelled as “capsules”. Affected batches together with further information can be found on the MHRA section on the GOV.UK website. Produced by the NPA Pharmacy Services team January 2020.…

Get involved in the next phase of the MHRA Fake Meds Campaign on self-test STI kits! #FakeMedsCampaign

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched the next phase of their Fake Meds Campaign, which focuses on self-test STI kits. The initial phase assisted in enforcement action against suppliers and resulted in 2,500 fake STI kits being seized. Fake self-test STI kits produce false results, consequently having a huge impact on patient’s wellbeing. This phase focuses on users most likely to purchase self-test STI kits; those aged between 18-30 years. It will assist potential users on how to identify fake STI kits and direct them to approved suppliers of self-test STI kits. Healthcare professionals including community pharmacists are in an ideal position to raise awareness of the campaign in this patient group. How can you support the campaign? Share campaign content through social media Use Twitter, Instagram and Facebook to share posts from the #FakeMedsCampaign Signpost patients to the campaign website Encourage them to use the ‘top tips’ for spotting fake self-test STI kits Contact the MHRA if you have further ideas to support this campaign Email details to engagement@mhra.gov.uk For further information on this or any other query, please contact the NPA Pharmacy Services team on 01727 891 800 or email pharmacyservices@npa.co.uk. Produced by the NPA Pharmacy Services team January 2020.…

NHS Community Pharmacist Consultation Service passes 100,000 referrals milestone in 10 weeks

Over one hundred thousand patients with minor illnesses or urgent medication needs have received same-day pharmacist referrals through the NHS Community Pharmacy Consultation Service (CPCS), according to figures released this weekend. Department of Health and Social Care figures reveal that: 10,600 pharmacies have registered to provide the service since October 2019 114,000 patients have benefitted from referrals to pharmacists via the CPCS Mark Lyonette, chief executive of the National Pharmacy Association said: “We are pleased that pharmacists, patients and the NHS are already embracing this new and important service, which offers people convenient care from highly skilled health care professionals.  Pharmacies are an indispensable component of the urgent care pathway – the first port of call for advice on minor illnesses as well as a vital support for people with long term medical conditions. “The NPA is delighted the NHS has recognised the potential to make greater use of the skills of community pharmacists in urgent care, which is something we have promoted for many years. We are committed to working with the NHS to ensure that implementation is widespread and effective.” The Community Pharmacist Consultation Service, launched by NHS England and NHS Improvement in October 2019, allows NHS 111 advisors to refer patients with minor illnesses to their local pharmacist for assessment and treatment.…

Important update: CPCS – low acuity or minor illness NPA SOP update, and urgent reminder regarding supply of CDs under the CPCS

Pharmacists and pharmacy teams should be aware that only patients referred by NHS 111 or Integrated Urgent Care Clinical Assessment Services (IUC CAS) are eligible to receive advice and treatment under the NHS Community Pharmacist Consultation Service (CPCS). The NPA Pharmacy Services team has updated the “SOP: Providing the NHS Community Pharmacist Consultation Service (CPCS) – Low acuity or minor illness (England)” to further clarify this.  Pharmacy contractors can provide patients with self-care advice and support, and treatment (if required and appropriate), under the NHS as part of the low acuity or minor illness strand of the CPCS. Pharmacy teams should be aware that only patients who have contacted NHS 111 or IUC CAS and have been referred to the pharmacy are entitled to receive advice and treatment under this service. Only these consultations can be completed on the CPCS IT system and a payment submission can be made to the NHS Business Services Authority (NHSBSA) via the Manage Your Service (MYS) portal and/or the CPCS IT system (Pharmoutcomes or Sonar) It is important to check the CPCS IT system or NHSmail regularly to determine if the patient has been referred to the pharmacy under the CPCS. Where no referral has been received but the patient has made contact with NHS 111 or IUC CAS, the pharmacist must contact the local NHS 111 or IUC CAS ‘health professionals telephone line’ (Annex C- Key Contact Details) to confirm the patient’s NHS number, GP details and request for the referral to be re-sent.…